An unusual case of glipizide-induced proximal myopathy
Saibal Das1★, Anand Ramasamy2, Soumyadip De1, Somnath Mondal3★ Corresponding author
- 1Nalmuri Block Primary Health Centre, South 24 Parganas, India.
- 2Department of Pharmacology, Swamy Vivekanandha College of Pharmacy, Namakkal, Tamil Nadu, India.
- 3Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India.
CORRESPONDENCE
Saibal Das
Nalmuri Block Primary Health Centre, South 24 Parganas, India.
Received: 03-04-2015; Revised: 19-04-2015; Accepted: 02-08-2015.
Volume 7, Issue 2 · pp. 99–101 · PUBLISHED 2016 · DOI: 10.4103/0976-500X.184775
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
This case report outlines a very rare case of glipizide‑induced severe proximal myopathy in a 61‑year‑old diabetic man. After taking 10 mg glipizide for 5 months, diabetes was well controlled but the patient presented with progressive proximal muscle weakness in all the four limbs. Clinical examination and relevant investigations suggested it to be a case of proximal myopathy and might be drug induced. De‑challenge was done and was treated resulting in reversal of the diseased state. After 3 more months, controlled re‑challenge was done and there was recurrence of proximal muscle weakness. There were no evidences of any other possible metabolic, infective, organic or other pathologic causes giving rise to that condition and Naranjo adverse drug reaction probability scale suggested that it was “probable” that glipizide was responsible for the development of myopathy in this patient.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Das, S., Ramasamy, A., De, S., & Mondal, S. (2016). An unusual case of glipizide-induced proximal myopathy. Journal of Pharmacology and Pharmacotherapeutics, 7(2), 99–101. https://doi.org/10.4103/0976-500X.184775